Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006)
Clinical trial NCT02121899 · TERMINATED
Trial details
- NCT number
- NCT02121899
- Sponsor
- Myriad Genetic Laboratories, Inc.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2015-04-01
- Primary completion
- 2017-06-30
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.